Company profile
AimerBio company profile
AimerBio is a pharmaceutical company that engages in the long-term modification of peptides and peptide-drug conjugation technology. At present, it has three technology platforms for peptide drug design, optimization and screening, long-acting peptide modification technology, peptide conjugated drugs, and 1 related invention patent. The company focuses on the field of peptide drugs, integrates today's international advanced peptide technology, establishes a peptide drug innovation technology platform, R&D pipeline, and product pipeline, and provides process technology development services and commercial production services for cooperative units. A first-class peptide pharmaceutical company.
Business identity
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2018-09-01
Headquarters
- Headquarters
- Anhui, China, Hefei
- Country code
- CN
- Continent
- Asia